在GLP-1激动剂和内镜手术的管理变化:一个标准化的机会
Javier Crespo1, María Jesús López-Arias2, Paula Iruzubieta2
1Gastroenterología y Hepatología, Hospital Universitario Marqués de Valdecilla, 39008.
Revista espanola de enfermedades digestivas
|January 15, 2025
概括
类似葡萄糖-1受体激动剂 (GLP-1RAs) 正在改变2型糖尿病和肥胖症治疗,提供显著的体重减轻. 新兴研究探讨了它们在治疗肝病,心血管问题等方面的潜力,这些问题与代谢和抗炎作用有关.
科学领域:
- 药理学和内分泌学 药理学和内分泌学
- 代谢疾病 代谢疾病
- 药物开发 药物开发
背景情况:
- 类似葡萄糖类-1受体激动剂 (GLP-1RAs) 或因克列模仿剂已成为2型糖尿病 (T2DM) 和肥胖症管理的基石.
- 这些药物因其有效性而超过了全球处方率的最初预测.
研究的目的:
- 审查GLP-1RAs的既定和新兴治疗应用.
- 探索它们超出代谢调节的类效应背后的机制.
主要方法:
- 临床试验和临床前研究的综合文献综述.
- 对GLP-1RAs和相关双/三重激动剂的药理学数据的分析.
主要成果:
- GLP-1RAs实现了显著的体重减轻,高达基线体重的20%.
- 研究用途包括代谢相关的脂肪性肝病,心血管疾病,神经认知障碍和成治疗.
结论:
- GLP-1RAs对T2DM和肥胖症具有显著的益处,具有不断扩大的治疗潜力.
- 它们在各种疾病中的有效性归因于代谢作用和慢性炎症调节.
相关概念视频
Glucagon-like Receptor Agonists
295
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
295
Oral Hypoglycemic Agents: Glinides
136
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
136
Dipeptidyl Peptidase 4 Inhibitors
165
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
165
Endoscopic Procedures I: Esophagogastroduodenoscopy
64
An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
During an EGD, the endoscope can be used to:
64
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
48
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
48
Endoscopic Procedures V: ERCP
79
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Patient...
79


